Elevated expression of urokinase plasminogen activator in rodent models and patients with cerebral amyloid angiopathy.

MLA

Vervuurt, Marc, et al. “Elevated Expression of Urokinase Plasminogen Activator in Rodent Models and Patients with Cerebral Amyloid Angiopathy.” Neuropathology and Applied Neurobiology, vol. 48, no. 5, Aug. 2022, p. e12804. EBSCOhost, https://doi.org/10.1111/nan.12804.

APA

Vervuurt, M., Zhu, X., Schrader, J., de Kort, A. M., Marques, T. M., Kersten, I., Peters van Ton, A. M., Abdo, W. F., Schreuder, F. H. B. M., Rasing, I., Terwindt, G. M., Wermer, M. J. H., Greenberg, S. M., Klijn, C. J. M., Kuiperij, H. B., Van Nostrand, W. E., & Verbeek, M. M. (2022). Elevated expression of urokinase plasminogen activator in rodent models and patients with cerebral amyloid angiopathy. Neuropathology and Applied Neurobiology, 48(5), e12804. https://doi.org/10.1111/nan.12804

Chicago

Vervuurt, Marc, Xiaoyue Zhu, Joseph Schrader, Anna M de Kort, Tainá M Marques, Iris Kersten, Annemieke M Peters van Ton, et al. 2022. “Elevated Expression of Urokinase Plasminogen Activator in Rodent Models and Patients with Cerebral Amyloid Angiopathy.” Neuropathology and Applied Neurobiology 48 (5): e12804. doi:10.1111/nan.12804.